RENALDO BARRIOS: Open Payments
NPI 1609865740 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 20 payments from 3 companies in 2025. Trend: 2023 $132 · 2024 $232 · 2025 $738
Food & beverage: $738
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 17 | $492 |
| Novo Nordisk Inc | 2 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
Products named: Wegovy, AIRSUPRA, Yeztugo, Biktarvy.
Industry payments across CA — which companies pay providers there.
